Desloratadine and loratadine stand out among common H1-antihistamines for association with improved breast cancer survival
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Desloratadine and loratadine stand out among common H1-antihistamines for association with improved breast cancer survival
Authors
Keywords
-
Journal
ACTA ONCOLOGICA
Volume -, Issue -, Pages 1-7
Publisher
Informa UK Limited
Online
2020-05-27
DOI
10.1080/0284186x.2020.1769185
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Desloratadine and loratadine use associated with improved melanoma survival
- (2020) Ildikó Fritz et al. ALLERGY
- Screening-based approach to discover effective platinum-based chemotherapies for cancers with poor prognosis
- (2019) Hristo P. Varbanov et al. PLoS One
- Antihistamines and ovarian cancer survival: nationwide cohort study and in vitro cell viability assay
- (2019) Freija Verdoodt et al. JNCI-Journal of the National Cancer Institute
- Histamine receptor 1 inhibition enhances antitumor therapeutic responses through extracellular signal-regulated kinase (ERK) activation in breast cancer
- (2018) Patricia Fernández-Nogueira et al. CANCER LETTERS
- Leukemic stem cell signatures identify novel therapeutics targeting acute myeloid leukemia
- (2018) Isabelle Laverdière et al. Blood Cancer Journal
- Repurposing Cationic Amphiphilic Antihistamines for Cancer Treatment
- (2016) Anne-Marie Ellegaard et al. EBioMedicine
- Everolimus Plus Exemestane for the Treatment of Advanced Breast Cancer: A Review of Subanalyses from BOLERO-2
- (2015) Gabriel N. Hortobagyi NEOPLASIA
- ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
- (2014) F. Cardoso et al. BREAST
- Estrogen and progesterone receptors in breast cancer
- (2014) Cheng-Har Yip et al. Future Oncology
- Risk of cancer in patients with medically diagnosed hay fever or allergic rhinitis
- (2014) Kari Hemminki et al. INTERNATIONAL JOURNAL OF CANCER
- Astemizole Synergizes Calcitriol Antiproliferative Activity by Inhibiting CYP24A1 and Upregulating VDR: A Novel Approach for Breast Cancer Therapy
- (2012) Janice García-Quiroz et al. PLoS One
- Terfenadine induces apoptosis and autophagy in melanoma cells through ROS-dependent and -independent mechanisms
- (2011) Francesca Nicolau-Galmés et al. APOPTOSIS
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Imputing missing covariate values for the Cox model
- (2009) Ian R. White et al. STATISTICS IN MEDICINE
- Clinical Pharmacokinetics and Pharmacodynamics of Desloratadine, Fexofenadine and Levocetirizine
- (2008) Philippe Devillier et al. CLINICAL PHARMACOKINETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started